Rocket Doctor AI Inc. (CSE:AIDR)
Canada · Delayed Price · Currency is CAD | Market Cap | 52.23M -14.0% |
| Revenue (ttm) | 38.14K |
| Net Income | -2.01M |
| EPS | -0.17 |
| Shares Out | 105.51M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 79,024 |
| Open | 0.4950 |
| Previous Close | 0.4900 |
| Day's Range | 0.4900 - 0.5200 |
| 52-Week Range | 0.4750 - 0.9800 |
| Beta | -0.25 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Oct 30, 2026 |
About Rocket Doctor AI
Rocket Doctor AI Inc. provides personalized health care information services in Canada and United States. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.... [Read more]
Financial Performance
Financial StatementsNews
Rocket Doctor AI Slides: Investor presentation
Rocket Doctor AI has posted slides in relation to its latest quarterly earnings report, which was published on October 1, 2026.
Rocket Doctor AI Provides Operational Update for U.S. Operations for First Two Months of Q3 2026 Ahead of Global Company Town Hall
Vancouver, B.C., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939) ("Rocket Doctor AI" or the "Company"), a physician-built, AI-powered healthcare te...
Rocket Doctor AI Transcript: Town Hall - September 2026
U.S. expansion reached 24M covered lives, with 3,900 completed Q2 visits and 3,600 visits in Q3’s first two months. Credentialing and payer reimbursement create a multi-month lag before revenue recognition; value-based contracts add recurring member payments.
Rocket Doctor AI Slides: FY 2026
Rocket Doctor AI has posted slides in relation to its FY 2026 quarterly earnings report, which was published on September 14, 2026.
Rocket Doctor AI Announces Global Company Town Hall to Showcase Q2 2026 Milestones and Strategic Vision
Vancouver, BC, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare tech...
Rocket Doctor AI Earnings release: Q2 2026
Rocket Doctor AI released its Q2 2026 earnings on August 31, 2026, summarizing the period's financial results.
Rocket Doctor AI Report: Q2 2026
Rocket Doctor AI published a report on August 31, 2026 containing material business information for investors and shareholders.
Rocket Doctor AI MD&A: Q2 2026
Rocket Doctor AI filed a regulatory document on August 31, 2026 disclosing important business information.
Rocket Doctor Grants Equity
Vancouver, British Columbia, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939) (“Rocket Doctor AI” or the “Company”) announces that it has granted an ...
Rocket Doctor AI Inc. Announces Non-Brokered Private Placement of Unsecured Convertible Debentures
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States Not for di...
Rocket Doctor Joins National Coalition Advocating for Permanent Medicare Telehealth
Vancouver, BC, July 21, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) ("Rocket Doctor AI" or the "Company") today announced that its wholly owned digital healt...
Rocket Doctor AI Inc. Appoints Financial Growth Strategist Andrew Lau as Chief Financial Officer to Help Accelerate U.S. Expansion
Vancouver, BC, July 07, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939) ("Rocket Doctor AI") is pleased to announce the appointment of Mr. Andrew Lau, CPA, C...
Rocket Doctor AI Transcript: Life Sciences Virtual Investor Forum
The platform combines proprietary clinical AI, clinician tools, and patient access, with U.S. expansion across three states and 21M+ in-network lives. Latest-quarter revenue was cited at CAD 750,000 with 75% gross margins, alongside rapid U.S. visit growth.
Rocket Doctor AI Slides: Life Sciences Virtual Investor Forum
Rocket Doctor AI has posted slides in relation to its latest quarterly earnings report, which was published on June 26, 2026.
Rocket Doctor Partners with Mindstride to Expand Access to After-Hours Healthcare Across Ontario, Alberta and British Columbia
Vancouver, BC, June 23, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939) (“Rocket Doctor AI”) today announced its wholly-owned digital health platform and mar...
Rocket Doctor Grants Stock Options and RSUs
Vancouver, BC, June 12, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939) (“Rocket Doctor AI”) has granted an aggregate 47,013 stock options, exercisable at $0...
Rocket Doctor AI Transcript: Town Hall - June 2026
The platform combines curated clinical AI, physician practice infrastructure and payer access, with U.S. patient visits rising from March to April 2026 and a substantial physician pipeline in credentialing. Management plans continued organic growth and further U.S. state expansion.
Rocket Doctor AI Slides: FY 2026
Rocket Doctor AI has posted slides in relation to its FY 2026 quarterly earnings report, which was published on June 3, 2026.
Rocket Doctor AI Earnings release: Q1 2026
Rocket Doctor AI released its Q1 2026 earnings on June 1, 2026, summarizing the period's financial results.
Rocket Doctor AI Report: Q1 2026
Rocket Doctor AI published a report on June 1, 2026 containing material business information for investors and shareholders.
Rocket Doctor AI MD&A: Q1 2026
Rocket Doctor AI filed a regulatory document on June 1, 2026 disclosing important business information.
Rocket Doctor AI Announces Global Company Town Hall to Showcase 2025 Milestones; Q1 2026 Milestones and Strategic Vision
Vancouver, BC, May 27, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcare techno...
Rocket Doctor AI Earnings release: Q4 2025
Rocket Doctor AI released its Q4 2025 earnings on April 30, 2026, summarizing the period's financial results.
Rocket Doctor AI Report: Q4 2025
Rocket Doctor AI published a report on April 30, 2026 containing material business information for investors and shareholders.
Rocket Doctor AI MD&A: Q4 2025
Rocket Doctor AI filed a regulatory document on April 30, 2026 disclosing important business information.